Major advance in the fight against MDR-TB: four new short and effective treatments from independent clinical trials approved by the WHO

This week, the WHO recommended four new treatments for patients with MDR-TB.

Three of the regimens were from the End TB trial, and one was from the BEAT-

Tuberculosis trial. All four new recommendations include shorter-course treatments, and

the End TB regimens include some of the first endorsements of short-course treatments

for children, adolescents, and pregnant women. Learn more here.

Recent Posts

The Health Justice Initiative in South Africa has reported that the South African government is utilizing the Competition Act to...

Johnson and Johnson successfully applied for a patent extension on bedaquiline; however, in a big win for LMI countries, the company has...

Members of the resist TB team recently published an open access letter to the editor regarding the effectiveness of consilia. Please find...